Innovative medicine of Kuban, Год журнала: 2025, Номер 10(1), С. 101 - 109

Опубликована: Фев. 26, 2025

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are now uncovering new possibilities in the field of internal medicine owing to their diverse protective effects. In second part literature review, we explore potential applications SGLT2i hepatology, neurology, ophthalmology, and oncology, mechanisms action such drugs as dapagliflozin, empagliflozin, canagliflozin, etc, effect on different organs systems.

Язык: Английский